Edition:
United States

Fibrocell Science Inc (FCSC.OQ)

FCSC.OQ on NASDAQ Stock Exchange Capital Market

2.07USD
16 Nov 2018
Change (% chg)

$0.01 (+0.49%)
Prev Close
$2.06
Open
$2.04
Day's High
$2.14
Day's Low
$2.04
Volume
12,409
Avg. Vol
30,546
52-wk High
$8.95
52-wk Low
$1.75

Chart for

About

Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $18.54
Shares Outstanding(Mil.): 9.31
Dividend: --
Yield (%): --

Financials

  FCSC.OQ Industry Sector
P/E (TTM): -- 79.62 29.34
EPS (TTM): -0.38 -- --
ROI: -20.21 -0.41 13.58
ROE: -128.60 -3.13 15.11

BRIEF-Fibrocell Reports On Interim Results And Progress Of Phase 1/2 Clinical Trial Of FCX-007 Gene Therapy For Recessive Dystrophic Epidermolysis Bullosa

* FIBROCELL REPORTS ON INTERIM RESULTS AND PROGRESS OF PHASE 1/2 CLINICAL TRIAL OF FCX-007 GENE THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA

May 21 2018

Earnings vs. Estimates